Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U35
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,587
Award facts
- Contract value 100% obligated
- $10,586.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,586.68 on January 12, 2026, for the supply of Monovisc 88 mg/4 mL syringes. This non-competitive delivery order, issued by the Defense Logistics Agency, represents a firm fixed-price procurement with a completion date of January 13, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office. Monovisc is a viscosupplementation injection used for the treatment of osteoarthritis, indicating this procurement supports the medical supply needs of the Department of Defense healthcare system.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement reflects the Defense Logistics Agency's strategy to maintain flexible contract vehicles for ensuring consistent pharmaceutical and medical commodity availability to the Department of Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1U35?
SPE2DR26F1U35 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1U35 worth?
The government has obligated $10,587 on SPE2DR26F1U35.
Is contract SPE2DR26F1U35 an order under another contract?
Yes. SPE2DR26F1U35 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U35 competed?
The extent of competition for SPE2DR26F1U35 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award